From Rodents to Recovery: Development of Animal Models of Schizophrenia

ISSN： 1172-7047

Source： CNS Drugs, Vol.9, Iss.1, 1998-01, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamatergic Animal Models of Schizophrenia

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1593-1604

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

By Castner Stacy Goldman-Rakic Patricia Williams Graham

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 111-125

Springer Publishing Company

Access to resources Recommend Favorite

Unveiling mRNA Changes During Meiotic Progression and Pre-Implantation Development: Help from Large Animal Models

Current Pharmaceutical Design, Vol. 18, Iss. 3, 2012-01 ,pp. : 256-263

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of hyperfunctioning parathyroid diseases for drug development

By Imanishi Yasuo Inaba Masaaki Kawata Takehisa Nishizawa Yoshiki

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 727-740

Informa Healthcare

Access to resources Recommend Favorite

Cytomegalovirus antivirals and development of improved animal models

By McGregor Alistair Choi K. Yeon

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1245-1265

Informa Healthcare

Access to resources Recommend Favorite